2023-510299-29-00招募中2 期
A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central nervous system
Genenta Science S.p.A., Genenta Science S.p.A.3 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2024年2月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 27
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Genenta Science
Scientific
Genenta Science S.p.A.
研究点 (3)
Loading locations...
相似试验
尚未招募
1/2 期
Phase I/II ex vivo gene therapy clinical trial for RDEB using autologous skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector2024-518368-10-00Institut National De La Sante Et De La Recherche Medicale3
招募中
不适用
Autologous hematopoietic stem cell gene therapy in RAG-deficient severe combined immunodeficiency: pre-phase studysevere combined immunodeficiencyNL-OMON55430eids Universitair Medisch Centrum8
招募中
1 期
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-HemoglobinopathiesSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Beta-ThalassemiaTransfusion Dependent Beta-ThalassaemiaSickle Cell DiseaseNCT06647979Daniel Bauer10
进行中（未招募）
1 期
Gene Transfer for Sickle Cell DiseaseSickle Cell DiseaseNCT03282656David Williams10
招募中
2 期
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)Chronic Granulomatous DiseaseNCT07284641Paul Szabolcs25